Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol
Keywords: ARS2; CASP8AP2; Acute lymphoblastic leukemia; Relapse; Prognosis; Minimal residual disease;